Dango: The emoji predicting app
Emojis are widely used among several social networking platforms. Choosing the right emoji can sometimes be a challenge. With Dango, the choices are generated for you. Thinking is no longer…
Knitt Labs launches KnittBar, raises $50,000 on Kickstarter in six days
UTEST graduate company building a versatile, smart, modular power bar We've all been there: You reach over behind your TV to plug in yet another device to find your power…
Triphase announces positive results of phase 1 trial of Marizomib and Bevacizumab in malignant glioma
TORONTO and SAN DIEGO (June 4, 2016) — Triphase Accelerator Corporation, a private drug development company dedicated to advancing novel compounds through Phase 2 proof-of-concept, today announced positive results from its…
Dr. Raphael Hofstein in Biotechnology Focus: Canada’s Contagiously Creative Life Sciences Sector
Biotechnology Focus, a compendium of the Canadian life sciences industry, has published the following guest column by Dr. Raphael Hofstein, MaRS Innovation’s president & CEO, and Elizabeth Monier-Williams, director of…
Video: DashMD’s CEO and co-founder interviewed by Dx3 Canada
Amber Mac from Dx3 Canada interviewed Zack Fisch, CEO and co-founder of DashMD. In the video, Zack discusses DashMD's vision for a better healthcare system and what the company is doing in…
The BBC features Flybits and Ryerson University’s Digital Media Zone
"With massive amounts of cash being pumped into development by Google, Facebook, Microsoft and context-aware startups such as Flybits, the PA in everybody’s pocket could soon be a reality," Nick…
Formation Biologics Recognized As One of the Most Promising Life Science Companies by Rice Alliance
(May 31, 2016) – Formation Biologics was recognized as one of the Rice Alliance 10 Most Promising Life Science Companies at the 2016 Texas Life Science Forum hosted by the…
UTEST program announces investments in five U of T start-ups
Companies in fourth cohort developing products ranging from software to therapeutic platforms; applications for fifth cohort, in partnership with MLA48, open until May 27, 2016 TORONTO (May 9, 2016) —…
TrendMD graduates from Ycombinator and announces new partnerships
It’s been a busy quarter for UTEST company TrendMD. Fresh off their participation in Ycombinator’s Winter 2016 cohort, which was covered in TechCrunch, the company has announced partnerships with HighWire…
Triphase Accelerator Corporation expands collaboration with Celgene in developing Marizomib to treat gliomas
Company initiating two new clinical trials for recurrent and newly diagnosed malignant gliomas TORONTO and SAN DIEGO, (May 03, 2016) – Triphase Accelerator Corporation, a private drug development company dedicated to advancing…